A detailed history of Franklin Resources Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 34,155 shares of VERV stock, worth $184,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,155
Previous 34,155 -0.0%
Holding current value
$184,778
Previous $165,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.4 - $7.86 $26,021 - $46,484
5,914 Added 20.94%
34,155 $165,000
Q2 2024

Aug 14, 2024

BUY
$4.76 - $12.79 $15,798 - $42,450
3,319 Added 13.32%
28,241 $137,000
Q1 2024

May 13, 2024

BUY
$10.81 - $17.96 $129 - $215
12 Added 0.05%
24,922 $330,000
Q4 2023

Feb 09, 2024

BUY
$8.84 - $18.7 $220,204 - $465,817
24,910 New
24,910 $347,000

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $324M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.